MPM Asset Management LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
MPM Asset Management LLC disclosed 6 US equity positions worth $145.3m in its Q3 2024 13F filing. The largest position was TRDA at 48.7% of the reported book, followed by 2662247D and DYN.
What did MPM Asset Management LLC own in Q3 2024? Top 6 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TRDA Entrada Therapeutics, Inc. | 48.7% | $70.7m | 4,425,784 | – | ||
| 2 | 2662247D iTeos Therapeutics, Inc. | 19.2% | $28.0m | 2,738,785 | – | ||
| 3 | DYN Dyne Therapeutics, Inc. | Healthcare | 16.9% | $24.5m | 682,376 | – | |
| 4 | HOWL Werewolf Therapeutics, Inc. | 6.3% | $9.1m | 4,284,172 | – | ||
| 5 | RPTX Repare Therapeutics, Inc. | 5.3% | $7.7m | 2,242,636 | – | ||
| 6 | ADAPY Adaptimmune Therapeutics plc | Healthcare | 3.6% | $5.3m | 5,555,461 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.